ACE and obesity disorder: The ACE I/D polymorphism has been associated with higher serum ACE levels [41], obesity [42], hypertension [43], increased cardiovascular risk [44], and thrombophilia [45]; all clinical conditions related with more aggressive COVID-19 disease [45].